MedPath

Half-normal Saline in Atrial Fibrillation Ablation

Not Applicable
Completed
Conditions
Atrial Fibrillation
Interventions
Drug: Half-normal saline
Drug: Normal saline
Registration Number
NCT03498586
Lead Sponsor
Texas Cardiac Arrhythmia Research Foundation
Brief Summary

The study evaluates the use of half-normal saline as an irrigant for open-irrigated catheters during atrial fibrillation ablation. By increasing the efficacy of radiofrequency energy-mediated lesion formation, half-normal saline has the potential to reduce procedural times and improved acute and long-term outcomes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
99
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Half-normal salineHalf-normal saline-
Normal salineNormal saline-
Primary Outcome Measures
NameTimeMethod
acute pulmonary veins, and left atrial appendage (if applicable) reconnectionintraprocedural
total radiofrequency ablation time, and total procedure timeintraprocedural
freedom from atrial tachycardia/atrial fibrillation > 30 seconds without antiarrhythmic drugs1 year
Secondary Outcome Measures
NameTimeMethod
freedom from atrial tachycardia/atrial fibrillation > 30 seconds with or without antiarrhythmic drugs1 year
long-term pulmonary veins, left atrial appendage (if applicable), and coronary sinus (if applicable) reconnectionin case of a repeat procedure performed during the study follow-up (an average of 1 year)

Trial Locations

Locations (2)

Texas Cardiac Arrhythmia Institute, St. David's Medical Center

🇺🇸

Austin, Texas, United States

Sunnybrook Health Sciences Centre

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath